Sharekhan

RPG Life Sciences Ltd

Thu 7/05/2026,15:45:51 NSE: RPGLIFE

₹ 2492.00 113.90 (4.79%)
BUY NOW Buy RPG Life Sciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock RPG Life Sciences Ltd

Thu 7/05/2026,16:1:0

RPG Life Sciences Ltd

Thu 7/05/2026,15:45:51 | NSE : RPGLIFE

₹ 2492.00113.90 (4.79%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2400.00

Previous Close

₹ 2378.10

Volume

49294

Mkt Cap ( Rs. Cr)

₹4121.52

High

₹ 2524.90

Low

₹ 2378.20

52 Week High

₹ 2725.00

52 Week Low

₹ 1733.00

Book Value Per Share

₹ 112.21

Dividend Yield

0.00

Face Value

₹ 8.00

What’s Your Call?

Collective community sentiment on RPG Life Sciences Ltd

Your Vote -

Buy

55.56%

Hold

11.11%

Sell

33.33%

55.56%

9 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

2492.00

13

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

13

Option Chain

Analyzes market sentiment, predicts RPG Life Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    30 Apr 2026, 8:48PM The Company has informed about the recording of Earnings Call.

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Apr 2026, 8:39PM RPG Life Sciences Limited has informed the Exchange about Link of Recording

  • RPG Life Sciences - Copy of Newspaper Publication

    30 Apr 2026, 2:13PM Newspaper Publication

  • RPG Life Sciences - Investor Presentation

    30 Apr 2026, 2:04PM RPG Life Sciences Limited has informed the Exchange about Investor Presentation

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation

    30 Apr 2026, 2:04PM Investor Presentation

  • RPG Life Sciences - Amendment To The Code

    29 Apr 2026, 9:03PM Amendment to the Code

  • RPG Life Sciences - General Updates

    29 Apr 2026, 9:02PM Amendment to the Code

  • RPG Life Sciences - Corporate Action-Board to consider Dividend

    29 Apr 2026, 8:58PM Company has informed about dividend recommended by the Board

  • RPG Life Sciences - Record Date

    29 Apr 2026, 8:56PM RPG Life Sciences Limited has informed the Exchange that Record date for the purpose of DI is 19-Jun-2026.

  • RPG Life Sciences - Appointment

    29 Apr 2026, 8:50PM Appointment of Mr Pratit Samdani as Additional Non- Executive Independent Director of the company w.e.f. April 29, 2026.

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Change in Management

    29 Apr 2026, 8:50PM Change in Management

  • RPG Life Sciences - Press Release

    29 Apr 2026, 8:45PM Press Release

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    29 Apr 2026, 8:44PM Press Release

  • RPG Life Sciences Q4 net profit down 74.52% at Rs 29.90 cr

    29 Apr 2026, 8:40PM The company reported standalone net profit of Rs 29.90 crore for the quarter ended March 31, 2026 as compared to Rs 117.35 crore in the same period la

  • RPG Life Sciences - Financial Results

    29 Apr 2026, 8:38PM Financial Results for Quarter and Yer ended on March 31, 2026

  • RPG Life Sciences - Outcome of Board Meeting

    29 Apr 2026, 8:37PM Financial results for the quarter and year ended March 31, 2026.

  • RPG Life Sciences - Outcome of Board Meeting

    29 Apr 2026, 8:27PM Outcome of Board Meeting

  • RPG Life Sciences - Board Meeting Outcome for Outcome Of Board Meeting

    29 Apr 2026, 8:22PM Outcome of Board Meeting

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 Apr 2026, 9:17PM Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please note the schedule of earnings call intimation

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Apr 2026, 9:13PM RPG Life Sciences Limited has informed the Exchange about Schedule of meet

  • RPG Life Sciences - Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Of T

    22 Apr 2026, 7:18PM RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 ,inter alia, to consider an

  • RPG Life Sciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    20 Apr 2026, 8:10PM As of March 2026, 72.95% is owned by Indian Promoters and 27.05% by Public. <p align=justify> Institutional holds 8.32% (Insurance Companies 0.21%) an

  • RPG Life Sciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2026, 4:24PM RPG Life Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • RPG Life Sciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2026, 4:21PM Certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018

  • RPG Life Sciences - Copy of Newspaper Publication

    7 Apr 2026, 6:32PM Newspaper Advertisement in respect to a special window opened for lodgment of transfer and dematerialization request(s)

  • RPG Life Sciences - Updates

    6 Apr 2026, 7:33PM RPG Life Sciences Limited has informed the Exchange regarding- ""Second -100 Days Campaign - Saksham Niveshak""

  • RPG Life Sciences - Intimation To Exchange About \Second -100 Days Campaign - Saksham Niveshak\

    6 Apr 2026, 7:33PM RPG Life Sciences Limited has informed the Exchange regarding - \Second -100 Days Campaign - Saksham Niveshak\

  • RPG Life Sciences - Trading Window

    24 Mar 2026, 8:03PM RPG Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • RPG Life Sciences - Copy of Newspaper Publication

    10 Feb 2026, 4:33PM RPG Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication regarding Special Window for Re-lodgment of transfer requests

  • RPG Life Sciences - Reply to Clarification- Financial results

    9 Feb 2026, 1:11PM The Exchange had sought clarification from RPG Life Sciences Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (List
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of RPG Life Sciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 530.53 374.85 307.61 256.06 217.71
Liabilities 530.53 374.85 307.61 256.06 217.71
Equity 13.23 13.23 13.23 13.23 13.23
Gross Profit 159.65 128.15 102.69 86.36 69.93
Net Profit 183.24 87.66 67.64 51.48 40
Cash From Operating Activities 77.86 94.36 90.82 64.75 58.27
NPM(%) 28.04 15.06 13.19 11.69 10.27
Revenue 653.43 582.05 512.81 440.16 389.14
Expenses 493.78 453.9 410.12 353.8 319.21
ROE(%) 98.73 47.23 36.44 27.73 21.55

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
24 300 0 2030.5
27 Jun 2025 4 50 0 2091.3
27 Jun 2025 20 250 0 2174.5
28 Jun 2024 16 200 0 1546.4
14 Jul 2022 9.6 120 0 590.65
13 Aug 2021 7.2 90 0 485.1
24 Mar 2020 4 50 0 219.05
22 Jul 2019 2.4 30 0 234.7
19 Jul 2018 2.4 30 0 412.1
13 Jul 2017 2.8 35 0 440.15
22 Mar 2016 1.6 20 0 252.3
20 Jul 2015 0.8 10 0 140.15
11 Sep 2014 1.2 15 0 70.6
11 Jul 2013 1.2 15 0 61.55
24 Jul 2012 0.8 10 0 64
14 Jul 2011 1.6 20 0 80
15 Jul 2010 1.44 18 0 70.65
30 Jul 2009 1.2 15 0 31.35
11 Aug 2008 1.2 15 0 25.75

Peers

Other companies within the same industry or sector that are comparable to RPG Life Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 789.75 -2.07 46.90 1415.93 301.39 0.63
Lotus Eye Hospital and Institute Ltd 116.99 -0.57 377.39 5159.46 3.55 0.00
Vaishali Pharma Ltd 7.46 -1.58 0.00 32367.00 3.13 0.00
Astec Lifesciences Ltd 715.25 0.44 0.00 4865.49 -363.15 0.00

Company Info

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

Read More

Parent Organisation

RPG Life Sciences Ltd.

Founded

29/03/2007

Managing Director

Mr.Ashok Nair

NSE Symbol

RPGLIFEEQ

FAQ

The current price of RPG Life Sciences Ltd is ₹ 2492.00.

The 52-week high for RPG Life Sciences Ltd is ₹ 2524.90 and the 52-week low is ₹ 2378.20.

The market capitalization of RPG Life Sciences Ltd is currently ₹ 4121.52. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy RPG Life Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in RPG Life Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase RPG Life Sciences Ltd shares.

The CEO of RPG Life Sciences Ltd is Mr.Ashok Nair, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT